The Latest Cardiac and Vascular News
IRVINE, Calif., Sept. 12, 2022 /PRNewswire/ — Edwards Lifesciences ( NYSE: EW) today announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards’ breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve. The launch follows recent U.S. Food and Drug Administration (FDA) approval. RESILIA tissue is […]
PHILADELPHIA, Sept. 12, 2022 (GLOBE NEWSWIRE) — The ŌNŌ endovascular retrieval system was recently used to remove a malpositioned leadless pacemaker (LPM) that embolized to the right pulmonary artery in a 52- year-old patient, ŌNŌCOR LLC announced today. The team at UCLA Medical Center, Los Angeles, California, percutaneously removed the […]
Results reinforce that Amplatzer Piccolo™ Occluder is safe and effective for closing an opening in the heart known as a “patent ductus arteriosus” (PDA) in newborns Study found low adverse event rates following a Piccolo procedure, showing additional benefit of the device that can help babies avoid riskier surgery A […]
Designed to Leverage AI Technology to Improve the Delivery of Connected Care in Cardiac Diagnostics and Remote Patient Monitoring LAKE OSWEGO, Ore., Sept. 8, 2022 /PRNewswire/ — BIOTRONIK announced today its partnership with AliveCor, a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology and services. This partnership will combine the strengths of BIOTRONIK’s BIOMONITOR Injectable […]
SHANGHAI, Sept. 8, 2022 /PRNewswire/ — Pulnovo Medical Limited, a globally recognized OTM innovative platform, today announced that it has successfully concluded the first Steering Committee meeting for PADN Global Clinical Trial. As members of the Steering Committee, the world’s leading cardiopulmonary experts presented and discussed about the future clinical workflow and the latest […]
The partnership will bring medically supported virtual cardiac rehabilitation and recovery into the homes of patients in Tampa General’s 23-county service area NEW YORK & TAMPA, Fla., Sept. 08, 2022 (GLOBE NEWSWIRE) — Recora today announced that it is partnering with the Tampa General Hospital Heart & Vascular Institute for its Cardiac Recovery Program. […]
HANOVER, Germany–(BUSINESS WIRE)–Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the CE marking of its PCR kit which measures circulating microRNA-132 (miR-132) levels in the blood of patients receiving the company’s lead candidate CDR132L, an oligonucleotide-based miR-132 inhibitor. The company […]
– Study Results Validate the Hypothesis That TTR Silencing by an RNAi Therapeutic has the Potential to be an Effective Approach for Treating Cardiomyopathy of ATTR Amyloidosis – – Patisiran met Primary Endpoint, Demonstrating Significant Clinical Benefit on Functional Capacity (6-MWT) Compared to Placebo at Month 12 – – Patisiran […]
Collaboration will advance the development of compounds designed by Gatehouse Bio’s AI-Powered platform September 08, 2022 08:16 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Gatehouse Bio, a pioneer in small RNA therapeutics, and AstraZeneca, a global, science-led biopharmaceutical company, are advancing their partnership, to create RNA therapeutics for the treatment of heart failure […]
SHANGHAI, Sept. 7, 2022 /PRNewswire/ — A globally recognized OTM innovative platform Pulnovo Medical Limited’s proprietary Pulmonary Artery Denervation (PADN) technology has been included in the 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of pulmonary arterial hypertension (PAH) (hereinafter referred to as “the Guidelines”), jointly issued by the European Society of Cardiology (ESC) […]
